Corcept Therapeutics Incorporated
DE ˙ DB ˙ US2183521028
63,24 € ↓ -0,74 (-1,16%)
2026-06-05
DEL PRIS
SecurityDE:HTD / Corcept Therapeutics Incorporated
InstitutionVictory Capital Management Inc
Latest Disclosed Ownership31,541 shares
Latest Disclosed Value $ 1,271,418
Victory Capital Management Inc reports 3.72% increase in ownership of HTD / Corcept Therapeutics Incorporated

On May 15, 2026 - Victory Capital Management Inc filed a 13F-HR form disclosing ownership of 31,541 shares of Corcept Therapeutics Incorporated (DE:HTD) valued at $1,087,849 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 30,409 shares of Corcept Therapeutics Incorporated. This represents a change in shares of 3.72% during the quarter. The current value of the position is $1,994,653 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F CORCEPT THERAPEUTICS COM 218352102 31,541 1,132 3.72 1,271 20.13 0.0006
2026-02-13 2025-12-31 13F CORCEPT THERAPEUTICS COM 218352102 30,409 -30,685 -50.23 1,058 -79.16 0.0006
2025-11-12 2025-09-30 13F CORCEPT THERAPEUTICS COM 218352102 61,094 -20,533 -25.15 5,078 -15.26 0.0030
2025-08-13 2025-06-30 13F CORCEPT THERAPEUTICS COM 218352102 81,627 -11,791 -12.62 5,991 -43.85 0.0039
2025-05-02 2025-03-31 13F CORCEPT THERAPEUTICS COM 218352102 93,418 18,389 24.51 10,670 182.28 0.0109
2025-02-06 2024-12-31 13F CORCEPT THERAPEUTICS COM 218352102 75,029 33,206 79.40 3,781 95.35 0.0037
2024-11-05 2024-09-30 13F CORCEPT THERAPEUTICS COM 218352102 41,823 13,787 49.18 1,936 112.64 0.0019
2024-08-05 2024-06-30 13F CORCEPT THERAPEUTICS COM 218352102 28,036 -6,810 -19.54 911 3.76 0.0009
2024-05-03 2024-03-31 13F CORCEPT THERAPEUTICS COM 218352102 34,846 -11,885 -25.43 878 -42.19 0.0009
2024-02-05 2023-12-31 13F CORCEPT THERAPEUTICS COM 218352102 46,731 -32,358 -40.91 1,518 -29.57 0.0016
2023-11-06 2023-09-30 13F CORCEPT THERAPEUTICS COM 218352102 79,089 -99,896 -55.81 2,155 -45.91 0.0025
2023-07-27 2023-06-30 13F CORCEPT THERAPEUTICS COM 218352102 178,985 -2,345 -1.29 3,982 1.40 0.0044
2023-05-02 2023-03-31 13F CORCEPT THERAPEUTICS COM 218352102 181,330 4,744 2.69 3,928 9.51 0.0044
2023-04-25 2022-12-31 13F/A-3 CORCEPT THERAPEUTICS COM 218352102 176,586 54,762 44.95 3,586 14.83 0.0041
2023-03-10 2022-12-31 13F/A-2 CORCEPT THERAPEUTICS COM 218352102 176,586 54,762 3,586 0.0025
2023-02-10 2022-12-31 13F/A-1 CORCEPT THERAPEUTICS COM 218352102 176,586 54,762 3,586 0.0025
2023-02-09 2022-12-31 13F CORCEPT THERAPEUTICS COM 218352102 171,342 49,518 3,748 0.0025
2022-11-02 2022-09-30 13F CORCEPT THERAPEUTICS COM 218352102 121,824 -4,664 -3.69 3,123 3.82 0.0036
2022-08-01 2022-06-30 13F CORCEPT THERAPEUTICS COM 218352102 126,488 -5,582 -4.23 3,008 3.33 0.0034
2022-05-04 2022-03-31 13F CORCEPT THERAPEUTICS COM 218352102 132,070 -2,149 -1.60 2,911 9.56 0.0029
2022-02-07 2021-12-31 13F CORCEPT THERAPEUTICS COM 218352102 134,219 3,326 2.54 2,657 3.14 0.0024
2021-11-02 2021-09-30 13F CORCEPT THERAPEUTICS COM 218352102 130,893 77,404 144.71 2,576 119.05 0.0025
2021-08-03 2021-06-30 13F CORCEPT THERAPEUTICS COM 218352102 53,489 2,093 4.07 1,176 -3.84 0.0011
2021-05-04 2021-03-31 13F CORCEPT THERAPEUTICS COM 218352102 51,396 -18,520 -26.49 1,223 -33.13 0.0013
2021-02-01 2020-12-31 13F CORCEPT THERAPEUTICS COM 218352102 69,916 -47,477 -40.44 1,829 -10.47 0.0020
2020-11-09 2020-09-30 13F Corcept Therapeutics COM 218352102 117,393 944 0.81 2,043 4.29 0.0026
2020-08-07 2020-06-30 13F CORCEPT THERAPEUTICS COM 218352102 116,449 37,359 47.24 1,959 108.40 0.0027
2020-05-12 2020-03-31 13F/A-1 CORCEPT THERAPEUTICS COM 218352102 79,090 11,857 17.64 940 15.48 0.0016
2020-05-04 2020-03-31 13F CORCEPT THERAPEUTICS COM 218352102 79,090 11,857 940 1,028.7345
2020-02-06 2019-12-31 13F/A-1 CORCEPT THERAPEUTICS COM 218352102 67,233 8,146 13.79 814 -2.51 0.0010
2020-02-04 2019-12-31 13F CORCEPT THERAPEUTICS COM 218352102 66,416 7,329 841 1,008.0988
2019-11-12 2019-09-30 13F CORCEPT THERAPEUTICS COM 218352102 59,087 54,549 1,202.05 835 1,537.25 0.0011
2019-08-15 2019-06-30 13F CORCEPT THERAPEUTICS COM 218352102 4,538 -7,883 -63.47 51 -65.07 0.0001
2019-05-03 2019-03-31 13F CORCEPT THERAPEUTICS CS 218352102 12,421 -6,835 -35.50 146 -43.19 0.0003
2019-05-02 2018-12-31 13F/A-1 CORCEPT THERAPEUTICS COM 218352102 19,256 752 4.06 257 -0.77 0.0006
2019-02-05 2018-12-31 13F CORCEPT THERAPEUTICS COM 218352102 19,256 752 257
2018-11-01 2018-09-30 13F CORCEPT THERAPEUTICS COM 218352102 18,504 9,416 103.61 259 81.12 0.0005
2018-08-02 2018-06-30 13F CORCEPT THERAPEUTICS COM 218352102 9,088 1,247 15.90 143 10.85 0.0003
2018-05-04 2018-03-31 13F CORCEPT THERAPEUTICS COM 218352102 7,841 1,725 28.20 129 17.27 0.0003
2018-02-01 2017-12-31 13F CORCEPT THERAPEUTICS COM 218352102 6,116 532 9.53 110 1.85 0.0002
2017-10-27 2017-09-30 13F CORCEPT THERAPEUTICS COM 218352102 5,584 5,584 108 0.0002
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.